Aiberry Secures $8M in Seed Funding to Accelerate AI-Powered Mental Health Screenings

CCG-led round will be used to drive rapid adoption of new digital platform that eliminates inaccuracy and bias in identification of people suffering from mental health disorders Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced that it has secured $8 million in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI. The new funds, which bring total funding to $10M, will be used to accelerate adoption of the Aiberry platform, which uses an AI-powered therapeutic assistant to conduct a conversation to detect mental health disorders by analyzing what is being said, the speech patterns being used and even subtle changes in facial expressions. Mental health issues are widespread and growing rapidly. The World Health Organization estimated in 2019 that 280 million people in the world have depression, while the National Center for Health Statistics’ (NCHS) estimated in 2021 that 11.7% of the adult population in the U.S. regularly had feelings of worry, nervousness, or anxiety. The need for rapid, easily administered, effective diagnosis has never been greater. “Our investment thesis is to apply artificial intelligence to solve practical problems in healthcare so that it drastically improves outcomes,” said Stewart Williams, Partner at Confluence Capital Group. “Healthcare leader Linda Chung and veteran technology leader Johan Bjorklund, Co-Fou...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: AI/Machine Learning Health IT Company Healthcare IT Aiberry Artificial Intelligence Ascension AI CCG Confluence Capital Group Confluence Capital Group Inc. Dr. Newton Howard Dr. Tammy Malloy Futures Recovery Healthcare Georgetown U Source Type: blogs